Beyond the incision: assessing bleeding risks in early aspirin administration post coronary artery bypass grafting

Area of Science:

• Cardiovascular Surgery
• Pharmacology
• Clinical Medicine

Background:

• Guidelines recommend early aspirin loading (150-325 mg) within 6 hours of coronary artery bypass grafting (CABG) to enhance vein graft patency.
• Concerns regarding increased bleeding risk have limited the adoption of early aspirin administration as a standard practice post-CABG.

Purpose of the Study:

• To evaluate the safety of early aspirin administration (within 6 hours) following coronary artery bypass grafting (CABG).
• To determine if early aspirin use is associated with an increased risk of bleeding complications.

Main Methods:

• A comparative study involving 160 patients undergoing CABG, divided into two groups: early aspirin (300 mg within 6 hours) and control.
• Assessment of bleeding risk included drainage output, red cell and platelet transfusion rates, pericardial effusion, and re-exploration for bleeding.
• Statistical analysis was performed to compare outcomes between the two groups, with significance set at p < 0.05.

Main Results:

• No significant differences in mean 24-hour drainage output were observed between the early aspirin group (695.7 mL) and the control group (712.7 mL).
• Rates of red cell transfusion (p=0.734), platelet transfusion (p=0.274), re-exploration for bleeding (p=0.694), and pericardial effusion (p=0.472) were statistically similar between groups.
• Analysis across 11 timepoints confirmed no significant differences in bleeding-related outcomes.

Conclusions:

• Early administration of 300 mg aspirin within 6 hours of CABG surgery does not lead to a statistically significant increase in bleeding or associated complications.
• The findings suggest that early aspirin use post-CABG is safe and may be considered to improve graft patency without compromising patient safety.